Ra'ayoyin Shuɗin Methylene da Rahotannin Reddit: Yadda Za A Karanta Su

Rubuta “ra'ayoyin masu amfani da shuɗin methylene” a akwatin bincike, kuma rahotanni za su bayyana kafin gwaje-gwajen bincike. Wani ya rubuta cewa ya sake samun kuzari da rana. Wani kuma ya rubuta cewa babu abin da ya faru. Na uku ya bayyana wata mummunar dare sannan ya daina wallafawa. Abin da kan ja hankali shi ne a ƙidaya su: idan mutane da yawa sun bayyana sauyi iri ɗaya, lallai akwai wani abu a ciki.

Tarin rahotannin mutum ɗaya ba ƙaramin gwajin asibiti ba ne. Wani abu ne dabam, wanda mutanen da ba su taɓa amincewa da zama samfurin bincike ba suka tattara.

Abin da rahoto guda ya ƙunsa

Ka ɗauki wani rubutu mai kama da wanda ake gani a zahiri: “Mako biyu ina amfani da shuɗin methylene, ɗigo goma a ruwa kowace safiya. Hazo a tunani ya gushe, na sake jin kamar yadda nake a da.”

Akwai ikirari huɗu cikin waɗannan jimloli uku. An yi amfani da wani samfur, an yi amfani da wani adadi, wani lokaci ya wuce, kuma wani abu ya sauya. Muna karanta ikirari na ƙarshe mu ɗauki ukun farko a matsayin ƙarin bayani kawai, alhali su ne iyakokin rahoton. Samfurin shi ne duk abin da kwalbar ta ƙunsa. Adadin kuwa ƙidayar ɗigo ne, wanda ba aunawa ba ne. Sauyin ra'ayin mutum ne game da abin da ya ji, wanda mutumin da ya yi tsammanin wani abu zai faru ya tantance, ba tare da kwatantawa ko rubutaccen bayanin yanayin farko ba. Wannan lura guda ce, kuma ta gaskiya ce, domin mutumin ya ji wani bambanci. Amma har yanzu ba bayani ba ne kan dalilin wannan bambanci.

Wasu bayanai huɗu ma sun dace da wannan jimla: tsammani, wani abu dabam da ya sauya a lokaci guda, sauye-sauyen alamar da kanta, da sauyin yadda ake aunawa. Ba za a iya kawar da ko ɗaya daga cikinsu ta wannan rahoton kaɗai ba.

Mutanen da ba su ji wani sauyi ba ba su da dalili mai ƙarfi na rubutawa

Shaidar da ta fi bayyana cewa rahotannin intanet samfurin ne da ya karkace ta fito daga wani kwatantawa na 2014, wanda ya kwatanta ra'ayoyi 1,901 a Amazon game da hanyoyin rage nauyi da magungunan taimaka wa haihuwa da sakamakon gwaje-gwajen bincike. Bayan watanni shida suna bin tsarin abincin Atkins, 93% na waɗanda suka wallafa ra'ayoyi a intanet (64 cikin 69) sun ba da rahoton rasa aƙalla 10 kg, yayin da 27% na mahalarta gwajin (19 cikin 71) suka samu irin wannan sauyin. Kammalawar marubutan ita ce jimlar da ya kamata a tuna: “Bita a intanet tana nuna fa'idodin jiyya fiye da yadda suke, wataƙila saboda mutanen da suka samu sakamako mara kyau ba su cika son gaya wa wasu abubuwan da suka fuskanta ba.” Wanda ya samu sauƙi yana da labarin da zai bayar; wanda ya shafe makonni shida bai ji wani bambanci ba ba shi da abin da zai ba da rahoto a kai.

Alƙiblar wannan karkacewar ba ta tsaya wuri guda ba, kuma wannan yana koyar da mu wani abu. Wani nazari na 2025 kan rubuce-rubuce 369 a Reddit game da ƙarin abubuwan gina jiki don haihuwa ya gano akasin hakan: daga cikin marubuta 279 da suka ba da rahoton shan ƙarin abubuwan gina jiki, 9.3% sun bayyana tasiri mai kyau da suka ji, 12.9% kuma tasiri mara kyau, yayin da 21.1% suka nemi shawara. Ga dandalin da aka kafa don warware matsaloli, wannan shi ne tsarin da ake tsammani. Wani bincike dabam ya gano cewa marasa lafiya da suka shiga wata al'ummar tattaunawar lafiya a intanet suna da maki mafi girma na damuwa mai tsanani da fargaba fiye da waɗanda ba mambobi ba.

Haɗuwar irin rahotannin da ake gani siffa ce ta al'ummar dandalin, ba cikakkiyar ƙidayar sakamako ba.

Tsammani na cikin abubuwan da ke tasiri

Ƙin amincewar da aka saba ji ta shafi mutum ne: “Ni ba irin mutumin da tsammani ke ruɗawa ba ne.”

A 2010, wata ƙungiya ƙarƙashin jagorancin Harvard ta ba mutane 80 masu ciwon hanji mai saurin motsawa ko dai ƙwayoyin placebo da aka bayyana musu da gaskiya cewa ba su da sinadarin magani mai aiki, ko kuma babu jiyya kwata-kwata, tare da hulɗa iri ɗaya da ma'aikacin lafiya a rukunonin biyu. Bayan makonni uku, maki na kyautatuwar yanayi gaba ɗaya sun kasance 5.0 ± 1.5 a rukunin da ya san yana shan placebo, idan aka kwatanta da 3.9 ± 1.3 a rukunin da bai samu jiyya ba. Wani nazarin haɗa sakamakon gwaje-gwaje goma sha ɗaya da suka ƙunshi mahalarta 654 daga baya ya gano tasiri na haɗaɗɗen sakamako da ya kai daidaitacciyar karkacewa 0.72. Wanda ke shan shuɗin methylene ma ba ya cikin yanayin sanin cewa yana shan placebo: ya yi imanin cewa sinadarin yana aiki, shi ya zaɓe shi, shi ya biya kuɗinsa, kuma shi ne ke rubuta sakamakon.

Ma'aunin ayyukan jiki ma yana sauyawa. A wani binciken placebo mai daidaita tsammani da abin da aka bayar a tsakanin masu gudu, lokacin kammala gudun mita 1000 ya inganta ne kawai idan mahalarta sun yi imanin cewa sun sha caffeine, ko da kuwa akwai caffeine a ƙwayar ko babu: girman tasiri ya kasance 0.43 a yanayin da aka ruɗe su, idan aka kwatanta da 0.42 na ainihin caffeine. Faɗa musu cewa sun sha placebo bai haifar da ingantawa ba, ko da sun sha caffeine.

Babu wanda zai iya ɓoye launin

Yawancin ƙarin abubuwan gina jiki suna ba da damar aboki ya shirya ƙwayoyi masu kama da juna. Shuɗin methylene ba ya ba da wannan damar: idan aka sha ta baki, yana canza launin fitsari zuwa shuɗi ko kore, wani lokaci kuma launin bayan gida.

Wani gwajin 2016 da aka raba mahalarta bazuwar a mujallar Radiology ya kula da wannan sosai. Mahalarta sun karɓi ko dai 280 mg na shuɗin methylene na matakin USP ta baki, ko rinin abinci FD&C Blue No. 2 a cikin ƙwayoyi masu kama da juna waɗanda ba a iya ganin cikinsu. An kuma nemi su yi fitsari kafin shan adadin, amma kada su yi bayan haka har sai an gama ɗaukar hoton ciki, domin launin fitsari kada ya tona musu abin da suka karɓa. An rubuta ƙoƙarin da aka yi, haka kuma gazawarsa: duk mahalartan da suka karɓi shuɗin methylene sun ba da rahoton fitsari mai launin shuɗi daga baya, kuma babu wanda ya yi haka a rukunin placebo. Marubutan sun kira sauyin launin “wata alama da ta bayyana daga baya, wadda ta tabbatar da cewa sun karɓi maganin.”

Misali mafi girma ya nuna abin da hakan ke jawowa. Gwajin mataki na 3 na LMTM a 2016 ya raba marasa lafiya 891 masu cutar Alzheimer bazuwar, kuma ba shi da rukunin placebo ko kaɗan. Rukunin kwatantawarsa ya karɓi 4 mg sau biyu a rana, wanda marubutan suka ce an zaɓa “domin ci gaba da ɓoye rukunin da mutum yake dangane da sauyin launin fitsari ko bayan gida.” Da an ba da ƙwayar da ba ta da sinadarin magani mai aiki, da an gane ta a bayan gida. Binciken cutar sauyin yanayi mai hawa da sauka, inda mahalarta suka gwada jiyya daban-daban a jere, ya ɗauki marasa lafiya 37 kuma ya kira rukuninsa na 15 mg “placebo”. Ya yi irin wannan sassaucin ne domin kwatanta shi da rukunin 195 mg mai aiki.

Ka karanta waɗannan tsare-tsaren a matsayin gargaɗi game da gwajin da mutum ke yi a kansa. Idan ɗaruruwan marasa lafiya a gwajin da aka ba kuɗi, tare da ƙwayoyin da ba a iya ganin cikinsu da jerin rabon bazuwar da masanin ƙididdiga ya tsara, har yanzu sun iya gane rukunin da suke, to wanda ke ɗiga shi cikin gilashin ruwa a gida ya riga ya san abin da yake sha. Ɓoye bayanin ba abu ne mai wahala kawai a nan ba. Ba ya samuwa.

Alamar tana da nata jadawalin

Da wuya mutane su fara shan ƙarin abubuwan gina jiki a makon da suke jin daɗi. Suna farawa ne a mako mara kyau, wanda ke kawo komawa zuwa matsakaici: ƙimomin da suka yi nisa da matsakaici sukan dawo kusa da shi, ko an ɗauki wani mataki ko ba a ɗauka ba.

Ana iya auna wannan sauyin. A cikin rukunin marasa lafiya masu ciwon ƙasan baya na dogon lokaci da ba a yi wa jiyya ba, matsakaicin zafi a ma'aunin 0 zuwa 100 ya tashi daga 56 a ziyarar farko zuwa 54 bayan watanni biyu da 46 bayan watanni huɗu. Marubutan sun danganta wani ɓangaren wannan sauyin da kulawar da mutum ke samu saboda ana bincikensa, wani abin rikitarwa da ke cikin duk wani gwaji da mutum ke yi a kansa.

Samun sauƙi da kansa abu ne da ya zama ruwan dare a yanayin da mutane ke ambata yayin tattauna shuɗin methylene. Daga cikin marasa lafiya 79 masu ciwon gajiya mai ɗorewa wanda bai kai shekara biyu ba, kuma ba tare da wani shirin jiyya na tsari ba, 46% sun ba da rahoton samun sauƙi bayan shekara guda. A cikin rukunin mutane 1,266 da aka kwantar a asibiti saboda COVID-19, kimanin 65% na waɗanda suka ba da rahoton hazo a tunani, raguwar ƙwaƙwalwa, ko raguwar maida hankali a matsakaicin watanni 8.4 ba su ƙara ba da rahoton hakan a watanni 13.2 ba, yayin da wasu suka fara samun alamar a wannan lokacin. A cikin masu cutar damuwa mai tsanani da ba a yi wa jiyya ba, daga cibiyoyin kiwon lafiya na farko, an ƙiyasta cewa 23% suna fita daga yanayin cutar cikin watanni uku, 53% kuma cikin shekara guda.

Babu wani abu a cikin wannan da ke nufin shuɗin methylene ba ya yin komai. Wannan yana bayyana yanayin farko na kwatantawa da rahoton mutum ɗaya ba shi da shi, kuma sauyi irin wanda aka saba bayyanawa a rubutun dandalin tattaunawa yana cikin kewayon abin da ke faruwa da kansa.

Makin yana da nasa jadawalin

Maimaita aunawa yana sauya abin da ake aunawa. Manyan mutane masu lafiya da suka kammala babban jerin gwaje-gwajen ayyukan kwakwalwa da halayyar tunani sau bakwai cikin shekara guda sun inganta saboda maimaitawa kaɗai: tasirin sabawa da gwaji ya kai daidaitacciyar karkacewa 0.36 zuwa 1.19 yayin gwaje-gwaje akai-akai har zuwa wata na uku, bayan haka ƙwarewarsu ta tsaya a mataki ɗaya. Babban tsallen ya faru a zama na biyu. Ƙaruwar maki cikin makonni uku na gwajin horar da kwakwalwa na yau da kullum ita ce sakamakon da ake tsammani daga yin gwajin makonni uku a jere.

Ma'aunin da mutum ke tantance kansa da shi ma ba ya tsira daga wannan tasirin. Maimaita gwajin Beck Depression Inventory a wani samfurin ɗalibai ya haifar da raguwar maki da 40% cikin makonni takwas da aka danganta da maimaita aunawa kaɗai, wanda ya bayyana kimanin 10% na bambancin sakamako. “Ina tantance yanayin zuciyata kowace safiya kuma yana kyautatawa” jimla ce game da tantancewar kamar yadda take game da yanayin zuciyar.

Yawanci wani abu dabam ya sauya a lokaci guda

Yawancin mutanen da ke rubuta rahoto kan shuɗin methylene sun riga suna sauya wasu abubuwa: barci, motsa jiki, shan barasa, wani ƙarin sinadarin gina jiki, hasken rana, ko wani aikin da ke jawo damuwa da ya ƙare. Rahoton yana ambaton samfurin ne domin shi ne sabon abu a jerin, ba domin shi kaɗai ne ba.

Rahoto ba ya zuwa da adadin da aka tabbatar

Ɗigo su ne ma'aunin da aka saba amfani da shi a bitar shuɗin methylene, amma ba ma'aunin adadi ba ne. Wani bincike kan kwalaben ɗigawa 19 da ke ɗauke da adadin amfani da yawa ya gano cewa ƙarar ɗigo ɗaya tana daga 33.8 zuwa 63.4 microlitres, bambanci kusan ninki biyu tsakanin kwalabe, tare da karkatar da kwalba zuwa ƙaramin kusurwa yana samar da ƙananan ɗigo. “Ɗigo goma” daga wata kwalba na iya kusan ninka “ɗigo goma” daga wata, kuma rubutun yawanci ba ya ambaton yawan sinadarin a cikin ruwan. Don haka, ko an auna ƙarar sosai, ba za a iya juya ta zuwa nauyi ba. Jagorar ma'aunin adadin da ake sha tana bayyana abubuwan da wannan juyawa ke buƙata.

Adadi kuma yana da muhimmanci ta hanyar da ba ta bayyana kai tsaye ba, domin dangantakar adadi da amsar jiki ba madaidaiciyar layi ba ce. A gwaje-gwajen bera, 4 mg/kg ya inganta sabawar ɗabi'a da gane abubuwa, 50 zuwa 100 mg/kg ya rage gudu a ƙafafun gudun gwaji, kuma ƙananan taro na sinadarin sun ƙara amfani da oxygen a kwakwalwa a gwajin wajen jiki da bayan ba da adadin a cikin jiki. Marubutan sun bayyana wannan tsarin a matsayin wanda ya dogara da adadi a alƙiblo biyu. Bitar ƙwaƙwalwa da maida hankali tana rarraba binciken ɗan Adam bisa adadi saboda wannan dalilin. Saboda haka, bita mai kyau ba ta nuna adadin da zai yi maka aiki ba, kuma rahoton rashin jin wani sauyi ba ya kawar da yiwuwar samun amsa da wani adadi dabam.

Akwai kuma ƙarin tazara tsakanin adadin da aka sha da adadin da jiki ya samu. A wani binciken da manyan mutane masu lafiya 16 suka gwada hanyoyi daban-daban a jere, matsakaicin cikakkiyar samuwar sinadarin a jiki daga adadin ruwan da aka sha ta baki ya kasance 72.3%, tare da daidaitacciyar karkacewa ta maki 23.9 na kashi. Mutane biyu da suka sha adadi ɗaya da aka auna ba lallai su kai taro ɗaya na sinadarin a jini ba, kamar yadda bitar shanyewa da rarrabuwar sinadarin a jiki ta bayyana.

Rahoto ba ya zuwa da samfurin da aka tabbatar

Kowace bita, bita ce ta wata kwalba, kuma abin da aka auna a cikinta sau da yawa ya bambanta da abin da ke kan lakabi. Wani nazari kan kayayyakin melatonin 30 ya gano cewa fiye da 71% sun bambanta da abin da aka bayyana da fiye da 10%, daga 83% ƙasa da abin da aka ce suna ƙunshe da shi zuwa 478% sama da shi. Bambanci tsakanin rukunonin samarwa ya kai 465%, kuma an samu serotonin a takwas daga cikinsu. A cikin tarin ƙarin abubuwan gina jiki na ganye da na abinci 272 da aka danganta da raunin hanta, 51% suna da lakabin da bai dace da abin da ke ciki ba, wanda ya kai 82% a cikin kayayyakin steroid.

Shuɗin methylene yana da ƙa'idar ingancinsa, kuma sinadarin da aka yi don rini ba a ɗora masa wannan ƙa'idar. Samfurin da ya dace da ƙa'idar da ke cikin littafin ƙa'idojin magunguna ana gwada shi don tabbatar da ainihin sinadari, tsabta, ƙazantar sinadarai masu tushen carbon kamar Azure B, ragowar sinadaran narkarwa, ƙazantar sinadarai na asali, ragowar ƙonawa, iyakokin ƙwayoyin halitta, da gubar endotoxin ta ƙwayoyin cuta. Maƙalar ƙazanta da hanyoyin gwaji tana nuna waɗannan gwaje-gwajen da abin da sakamakon samfuran shuɗin methylene da aka wallafa ya ƙunsa da abin da bai ƙunsa ba.

Wannan shi ne ɓangaren shawarar saye da mai karatu zai iya tabbatarwa. Yawancin masu sayar da shuɗin methylene waɗanda ke tallata dacewa da USP suna gwada ƙarafa masu nauyi kaɗai, sannan su bayyana hakan a matsayin cikakkiyar bin ƙa'ida. Blupreme yana aiki da masana'antar shuɗin methylene ta magunguna, kuma yana wallafa takardun shaidar nazari na kowane rukunin samarwa waɗanda ke haɗa lambar rukunin da ke kan kwalba da rukunin sinadarin da aka gwada. Shafin bayanin matakin USP yana bayyana abin da ƙa'idar ta ƙunsa, kuma jagorar karanta takardar shaidar nazari tana nuna yadda za a daidaita rahoto da rukunin samarwar da ka karɓa.

Sanin abin da ke cikin kwalbar yana kawar da abin rikitarwa guda. Ba ya juya rahoton mutum ɗaya da ya san abin da ya sha zuwa shaida cewa samfurin ne ya haifar da sauyin.

Rahotannin da har yanzu ya dace a karanta

Bayanan mutum ɗaya shaida ce marar ƙarfi ta fa'ida, amma shaida ce mai dacewa ta wani abu dabam: matsala mai yiwuwa. Idan mutane da yawa, ba tare da dogaro da juna ba, sun bayyana amsa iri ɗaya mai wata siffa ta musamman, wannan zato ne da ma'aikacin lafiya zai iya bincika. Takaitaccen bayanin illolin gefe yana bayyana yadda za a bayyana abin da mutum ya samu da kuma inda za a iya ba da rahoton amsar da ake zargi. Jagorar yawan sha fiye da kima da guba tana tattauna ɓangaren da ke buƙatar gaggawa.

Rahotanni kuma suna gaya maka tambayoyin da za ka yi. Jerin tattaunawar mutanen da ba su yarda da juna ba kan ko shuɗin methylene ya taimaka wa barcinsu alama ce cewa ya dace a binciki barci a rubuce-rubucen gwaje-gwajen bincike, ba alama ce cewa shuɗin methylene yana taimaka wa barci ba. Bitar shaidar ɗan Adam tana nuna abin da waɗannan rubuce-rubucen suka ƙunsa, kuma ɗakin karatun bincike yana tattara gwaje-gwajen.

Karanta jerin tattaunawa ba tare da ruɗar da kanka ba

Tsarin gajere ne. Kwafi ikirarin daidai yadda yake. Raba abin da mutumin ya lura da shi daga abin da ya yanke hukunci a kai. Sannan ka jera bayanan dalili masu yiwuwa, ka tambayi wanne wannan rahoton ya kawar da shi. A yawancin lokuta, amsar gaskiya ita ce babu ko ɗaya, kuma matsayin rahoton shi ne ba a warware ba, maimakon gaskiya ko ƙarya.

Zazzage takardar aikin tantance labarin mutum ɗaya don yin wannan binciken a kan wani jerin tattaunawa na musamman. Tana jera bayanan da yawanci ba a bayar ba, wurin rubuta sauran bayanan dalili masu gasa, da tsarin rubuta bayanai ga duk wanda ya yanke shawarar gwada wani abu duk da haka.

Idan ka gwada wani abu a kanka, zaɓuɓɓuka huɗu za su sa bayanin ya fi rubutun da aka saba gani amfani: ka ƙayyade sakamakon da za ka auna da ma'aunin tantancewa kafin adadin farko, ka tattara bayanan yanayin farko na lokaci mai tsawo yadda zai nuna yadda alamar ke sauyawa a al'ada, ka sauya abu ɗaya a lokaci guda, kuma ka rubuta ranakun da abubuwa suka tafi ba daidai ba. Jagorar bincika tsarin amfani da aka samu a intanet tana amfani da wannan tsari na tsantseni wajen umarni maimakon abubuwan da mutane suka fuskanta.

Abubuwa biyu masu kamanceceniya suna rufe wannan bayani. Jin sauƙi ba ya tabbatar da cewa samfurin ne ya haifar da kyautatuwar, kuma rashin jin wani sauyi ba ya tabbatar da cewa samfurin ba ya yin komai a kowane adadi ko kowace siffa. Kurakuran biyu suna fitowa ne daga ɗaukar lura guda da aka yi ba tare da ɓoye abin da aka sha ba a matsayin sakamako. Abin da bita za ta iya ƙarawa shi ne dalilin bincikawa, da gargaɗin da ya dace a ɗauki mataki a kansa.